BNF:

10.3.2

Status:

Grey, Grey - after consultant/specialist recommendation

Decision Date:

January 2014

Comments

Capsaicin 0.075% cream

GREY after cons/spec recommendation: as per neuropathic pain guidance for patients who cannot take or tolerate oral medicines.   (Decision date - May 2017, April 2023).

Capsaicin 0.025% cream

GREY: can be considered as an adjunct after NSAIDs (topical or oral) with or without paracetamol in OA.  (Decision date - September 2017).

search again